Literature DB >> 3432036

Optimization of a formulation for direct compression using a simplex lattice design.

H V Van Kamp1, G K Bolhuis, C F Lerk.   

Abstract

In this paper it is demonstrated how the optimum composition of a mixture for direct compression consisting of alpha-lactose monohydrate, roller-dried beta-lactose and microcrystalline cellulose can be found using a systematic optimization technique. The experiments were chosen according to a simplex lattice design. The results of these experiments were used to fit a mathematical model, which then can predict the properties of all possible mixture compositions and enables a graphic representation of these properties in the form of contour plots. At a level of 4% the effect of three disintegrants (sodium starch glycolate, croscarmellose sodium and crospovidone) on the properties of the tablets compressed from these filler-binders, was evaluated by superimposing the contour plots of the different tablet responses. It was found that all the disintegrants used were effective in this combination of filler-binders. In order to evaluate drug dissolution rate an extra experiment with crospovidone as the disintegrant was performed, in which oxazepam was used as a test drug.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3432036     DOI: 10.1007/BF01953629

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  3 in total

1.  Studies on tableting properties of lactose. V. Effects of both lubrication and addition of disintegrants on properties of tablets prepared from different types of crystalline lactose.

Authors:  H V Van Kamp; G K Bolhuis; C F Lerk
Journal:  Acta Pharm Suec       Date:  1986

2.  Development and optimization of pharmaceutical formulations using a simplex lattice design.

Authors:  R Huisman; H V Van Kamp; J W Weyland; D A Doornbos; G K Bolhuis; C F Lerk
Journal:  Pharm Weekbl Sci       Date:  1984-10-19

3.  Effect of microcrystalline cellulose on liquid penetration in and disintegration of directly compressed tablets.

Authors:  C F Lerk; G K Bolhuis; A H de Boer
Journal:  J Pharm Sci       Date:  1979-02       Impact factor: 3.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.